Opiant Pharmaceuticals Inc (OQ:OPNT)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
Biogen (OQ:BIIB)
Allakos (OQ:ALLK)
BioMarin Pharmaceutical (OQ:BMRN)
Latest 10 SEC filings (by transaction date) for OPNT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 23rd, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 20/19 Sep 20/19 Mottiwala Aziz Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 20/19 Sep 20/19 Mottiwala Aziz Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 20/19 Sep 20/19 Thompson Rahsaan Direct Ownership Options Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 20/19 Sep 20/19 Thompson Rahsaan Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 13/19 Sep 12/19 Sinclair Michael Direct Ownership Common Stock S - Open market or private sale -60,000 $12.52
Sep 4/19 Sep 4/19 Skolnick Phil Direct Ownership Common Stock S - Open market or private sale -2,494 $14.37
Sep 4/19 Sep 3/19 Skolnick Phil Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Sep 4/19 Sep 3/19 Skolnick Phil Direct Ownership Common Stock S - Open market or private sale -7,506 $14.08
Sep 4/19 Sep 3/19 Skolnick Phil Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $9.00
Aug 15/19 Aug 15/19 O'Toole David D Direct Ownership Common Stock P - Open market or private purchase 1,000 $15.20
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for OPNT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 23rd, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 20/19 Sep 20/19 Mottiwala Aziz Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 20/19 Sep 20/19 Mottiwala Aziz Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 20/19 Sep 20/19 Thompson Rahsaan Direct Ownership Options Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 20/19 Sep 20/19 Thompson Rahsaan Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 13/19 Sep 12/19 Sinclair Michael Direct Ownership Common Stock S - Open market or private sale -60,000 $12.52
Sep 4/19 Sep 3/19 Skolnick Phil Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Sep 4/19 Sep 4/19 Skolnick Phil Direct Ownership Common Stock S - Open market or private sale -2,494 $14.37
Sep 4/19 Sep 3/19 Skolnick Phil Direct Ownership Common Stock S - Open market or private sale -7,506 $14.08
Sep 4/19 Sep 3/19 Skolnick Phil Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $9.00
Aug 15/19 Aug 15/19 O'Toole David D Direct Ownership Common Stock P - Open market or private purchase 1,000 $15.20
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $OPNT

StockTwits